forecast
Argenx Phase II approvals rely on mechanism
The probability of approval for Argenx's pipeline drugs is around 60 to 70 percent rather than the industry's 10 percent, because the company understands the biology it targets and the patient difference it makes.
forecastpending
Speaker
JuliaEvidence Quote
“they are not 10%, they are look more like 60%, 70%”
Created: 11/17/2026, 3:39:21 AM
Your notes
Loading notes...